Spectrum Pharma Shares Hit New High on Q4 Results – International Business Times

By Dr. Matthew Watson


International Business Times
Spectrum Pharma Shares Hit New High on Q4 Results
International Business Times
The Irvine, California-based biotechnology company reported fourth quarter earnings of $4 million or 8 cents a share, down from $10 million or 20 cents a share last year. The quarterly results included, among other things, loss related to change in ...
Spectrum Pharmaceuticals to Present at the 23rd Annual ROTH OC Growth Stock ...Business Wire (press release)
Spectrum Pharma Q4 Profit Drops - UpdateRTT News

all 39 news articles »



categoriaUncategorized commentoComments Off on Spectrum Pharma Shares Hit New High on Q4 Results – International Business Times | dataMarch 13th, 2011

About...

This author published 5432 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024